[go: up one dir, main page]

ES8304150A1 - "un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral". - Google Patents

"un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral".

Info

Publication number
ES8304150A1
ES8304150A1 ES511376A ES511376A ES8304150A1 ES 8304150 A1 ES8304150 A1 ES 8304150A1 ES 511376 A ES511376 A ES 511376A ES 511376 A ES511376 A ES 511376A ES 8304150 A1 ES8304150 A1 ES 8304150A1
Authority
ES
Spain
Prior art keywords
physiologically active
substance
active substance
procedure
active protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES511376A
Other languages
English (en)
Other versions
ES511376A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd, Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Dainippon Pharmaceutical Co Ltd
Priority to ES511376A priority Critical patent/ES511376A0/es
Publication of ES8304150A1 publication Critical patent/ES8304150A1/es
Publication of ES511376A0 publication Critical patent/ES511376A0/es
Granted legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA FABRICACION DE SUSTANCIAS PROTEINICAS FISIOLOGICAMENTE ACTIVAS, QUE TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTITUMORAL. CONSISTE EN PASAR UNA DISOLUCION CRUDA DE LA SUSTANCIA PROTEINICA DE PH 6,0 A 9,0 A TRAVES DE UN CAMBIADOR DE ANIONES BASICO; ELUIR LA SUSTANCIA FISIOLOGICAMENTE ACTIVA QUE HA SIDO ABSORBIDA; Y SOMETERLA A FILTRACION POR GEL, UTILIZANDO GELES PARA LA SEPARACION DE SUSTANCIAS DE PESO MOLECULAR ENTRE 30.000 Y 70.000, Y ELUYENDO CON UNA DISOLUCION DE PH ENTRE 6,0 Y 9,0.
ES511376A 1982-04-13 1982-04-13 "un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral". Granted ES511376A0 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES511376A ES511376A0 (es) 1982-04-13 1982-04-13 "un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral".

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES511376A ES511376A0 (es) 1982-04-13 1982-04-13 "un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral".

Publications (2)

Publication Number Publication Date
ES8304150A1 true ES8304150A1 (es) 1983-02-16
ES511376A0 ES511376A0 (es) 1983-02-16

Family

ID=8483993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511376A Granted ES511376A0 (es) 1982-04-13 1982-04-13 "un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral".

Country Status (1)

Country Link
ES (1) ES511376A0 (es)

Also Published As

Publication number Publication date
ES511376A0 (es) 1983-02-16

Similar Documents

Publication Publication Date Title
FR2524891B1 (fr) Procede pour purifier une substance proteinee douee d'activite antitumorale
JPH0231689A (ja) 百日咳トキシンの精製法
Kaufman et al. Purification of dihydrofolic reductase from chicken liver by affinity chromatography
US4440675A (en) Human immune interferon
GB1356911A (en) Purification and fractionation of carcinoembryonic antigen
JPH0586097A (ja) 上清iv、特にiv−4またはコーンフラクシヨンvまたはそれと類似の上清または画分からヒトアルブミンを単離する方法
RU2004121982A (ru) Способ очистки и/или выделения биологически активного гранулоцитарного колониестимулирующего фактора
US5853714A (en) Method for purification of IL-12
EP0087686A3 (en) Homogeneous human immune interferon and process therefor
US3925152A (en) Virus separation
GB1440369A (en) Purification of coenzyme a
ES8304150A1 (es) "un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral".
US5338834A (en) Ultrapure human interleukin-6
US4658017A (en) Method for the large scale purification of human fibroblast interferon
MY130013A (en) Purification of human interleukin-4 from a secreted escherichia coli mutant.
DK163582A (da) Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning
JPS57140726A (en) Purification of physiologically active substance having carcinostatic action
US5023320A (en) Process for the purification of physiologically active substance having antitumor activity
Braude [27] Purification of natural human immune interferon induced by A-23187 and Mezerein
GB1402349A (en) Purification process for gn-rh
US3651231A (en) Process for preparing lactogenic factor
Wong et al. High-performance liquid chromatography of proteins: Purification of α-fetoprotein from fetal calf serum
IT1212658B (it) Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale
RU1839190C (ru) Способ очистки микробной эстеразы
Grundboeck-Jusko et al. Immunosuppressive serum proteins from cattle affected with leukosis